Paul Sauter
Senior Director Chemistry & Bioconjugation, VERAXA Biotech GmbH
Paul Sauter holds a Ph.D. in organic chemistry from the Karlsruhe Institute of Technology and pursued post-doctoral studies at the European Molecular Biology Laboratory (EMBL), working on bioorthogonal click chemistry. He has been building VERAXA’s current ADC technology and ADC chemistry department since inception and is now leading the development off VERAXA’s dual targeting BiTAC ADC platform.
Events Paul Sauter has spoken at
- NextGen Biomed 2027 18 March 2027 – 19 March 2027